Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Adrenal Cortical Carcinoma”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Looking for participantsNCT04318730
What this trial is testing

Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
West China Hospital 21
Testing effectiveness (Phase 2)Ended earlyNCT00778817
What this trial is testing

IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Adrenocortical CarcinomaStage III Adrenocortical CarcinomaStage IV Adrenocortical Carcinoma
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)Ended earlyNCT03746431
What this trial is testing

[225Ac]-FPI-1434 Injection

Who this might be right for
Advanced Solid TumoursEndometrial CancerCervical Cancer+7 more
Fusion Pharmaceuticals Inc. 78
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Not applicableLooking for participantsNCT06050057
What this trial is testing

Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy

Who this might be right for
Adrenal TumorAdrenal DiseaseAdrenal Mass+10 more
University Hospital Olomouc 100
Testing effectiveness (Phase 2)Looking for participantsNCT06587802
What this trial is testing

Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Sun Yat-sen University 18
Testing effectiveness (Phase 2)Looking for participantsNCT06006013
What this trial is testing

Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer

Who this might be right for
Locally Advanced Adrenal Cortex CarcinomaAdrenal Cortical CarcinomaStage III Adrenal Cortex Carcinoma+2 more
Emory University 21
Testing effectiveness (Phase 2)Ended earlyNCT05012397
What this trial is testing

Milademetan in Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorsHead and Neck CarcinomaCholangiocarcinoma+15 more
Rain Oncology Inc 40
Testing effectiveness (Phase 2)Looking for participantsNCT06683846
What this trial is testing

Ivonescimab in the Treatment of Multiple Advanced Tumors

Who this might be right for
Pheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more
Fudan University 400
Testing effectiveness (Phase 2)Ended earlyNCT02720484
What this trial is testing

Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer

Who this might be right for
Metastatic Carcinoma in the Adrenal CortexRecurrent Adrenal Cortex CarcinomaStage III Adrenal Cortex Carcinoma+1 more
Northwestern University 10
Testing effectiveness (Phase 2)Looking for participantsNCT05286814
What this trial is testing

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Who this might be right for
Metastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT03370718
What this trial is testing

Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma

Who this might be right for
Metastatic Carcinoma in the Adrenal CortexStage III Adrenal Cortex Carcinoma AJCC v8Stage IV Adrenal Cortex Carcinoma AJCC v8+1 more
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Ended earlyNCT04187404
What this trial is testing

A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma

Who this might be right for
Adrenocortical CarcinomaPheochromocytomaParaganglioma
Enterome 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732
What this trial is testing

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
M.D. Anderson Cancer Center 157
Load More Results